321 related articles for article (PubMed ID: 16199919)
1. [Treatment of elderly hypertension with Ca channel blockers].
Saito F; Kushiro T
Clin Calcium; 2005 Oct; 15(10):1717-25. PubMed ID: 16199919
[TBL] [Abstract][Full Text] [Related]
2. [Calcium antagonists: current and future applications based on new evidence. Calcium channel blockers in the elderly with hypertension].
Ohishi M; Rakugi H
Clin Calcium; 2010 Jan; 20(1):100-6. PubMed ID: 20048441
[TBL] [Abstract][Full Text] [Related]
3. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
4. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
Burnier M; Pruijm M; Wuerzner G
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
[TBL] [Abstract][Full Text] [Related]
5. Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension.
Bramlage P
Expert Opin Pharmacother; 2009 Aug; 10(11):1755-67. PubMed ID: 19538001
[TBL] [Abstract][Full Text] [Related]
6. Current status of antihypertensive prescription and associated blood pressure control in Japan.
Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
[TBL] [Abstract][Full Text] [Related]
7. Use of calcium channel blockers as antihypertensives in relation to mortality and cancer incidence: a population-based observational study.
Lindberg G; Lindblad U; Löw-Larsen B; Merlo J; Melander A; Råstam L
Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):493-7. PubMed ID: 12426934
[TBL] [Abstract][Full Text] [Related]
8. Long-term safety of antihypertensive therapy.
Grossman E; Messerli FH
Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
[TBL] [Abstract][Full Text] [Related]
9. Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients.
Ogihara T; Saruta T; Rakugi H; Shimamoto K; Ito S; Matsuoka H; Horiuchi M; Imaizumi T; Takishita S; Higaki J; Katayama S; Saito I; Shimada K;
Hypertens Res; 2009 Feb; 32(2):163-7. PubMed ID: 19262477
[TBL] [Abstract][Full Text] [Related]
10. Calcium channel blockers and coronary heart disease.
Inzitari M; Di Bari M; Marchionni N
Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):6-15. PubMed ID: 16640169
[TBL] [Abstract][Full Text] [Related]
11. Aggressive blood pressure control and stroke prevention: role of calcium channel blockers.
Papadopoulos DP; Papademetriou V
J Hypertens; 2008 May; 26(5):844-52. PubMed ID: 18398322
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.
Cortez-Dias N; Martins S; Belo A; Fiuza M;
Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569
[TBL] [Abstract][Full Text] [Related]
13. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
Roberts ME; Epstein BJ
J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
[TBL] [Abstract][Full Text] [Related]
14. Extent of use of immediate-release formulations of calcium channel blockers as antihypertensive monotherapy by primary care physicians: multicentric study from Bahrain.
Sequeira RP; Jassim Al Khaja KA; Mathur VS
J Postgrad Med; 2002; 48(3):172-5. PubMed ID: 12432188
[TBL] [Abstract][Full Text] [Related]
15. Influence of calcium channel blockers in patients with gastrointestinal disease in Japanese community pharmacies.
Hamada A; Akiyoshi R; Ishii J; Hamada N; Miyazaki C; Hamada T; Ohwaki Y; Ikeda R; Wada M; Nakashima K
J Clin Pharm Ther; 2012 Feb; 37(1):74-7. PubMed ID: 21395634
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of hypertension in the elderly and its effects on the QOL].
Mikami H
Nihon Rinsho; 2005 Jun; 63(6):1096-100. PubMed ID: 15948397
[TBL] [Abstract][Full Text] [Related]
17. The T- and L-type calcium channel blocker (CCB) mibefradil attenuates leg edema induced by the L-type CCB nifedipine in the spontaneously hypertensive rat: a novel differentiating assay.
Major TC; Dhamija S; Black N; Liachenko S; Morenko B; Sobocinski G; Okerberg C; Tinholt P; Madore S; Kowala MC
J Pharmacol Exp Ther; 2008 Jun; 325(3):723-31. PubMed ID: 18326812
[TBL] [Abstract][Full Text] [Related]
18. Choice of antihypertensive drug in the diabetic patient.
Ong HT; Cheah JS
MedGenMed; 2005 May; 7(2):74. PubMed ID: 16369452
[TBL] [Abstract][Full Text] [Related]
19. Calcium antagonists in hypertension: first-line antihypertensive agents?
Ambrosioni E
Blood Press Suppl; 1996; 5():5-6. PubMed ID: 8973785
[TBL] [Abstract][Full Text] [Related]
20. Treatment of hypertension in the elderly.
Zanchetti A
Aging (Milano); 1998 Apr; 10(2):168-9. PubMed ID: 9666224
[No Abstract] [Full Text] [Related]
[Next] [New Search]
